Add to ORKGC19H16ClN2OS, orthorhombic, Pca2(1) (No. 29), a = 8.1148(1) Angstrom, b = 19.1264(2) Angstrom, c = 21.7702(2) Angstrom. V = 3383.0 Angstrom(3). Z = 8, R-gt(F) = 0.069, wR(ref)(F-2)= 0.188, T = 293 K
The asymmetric unit of the title compound, C34H28ClN3O3S, contains two independent molecules (A and ...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C15H14ClNO4, monoclinic, P21/n (no. 14), a = 14.188(3) Å, b = 5.6930(11) Å, c = 17.444(4) Å, β = 95....
C19H16ClN2OS, orthorhombic, Pca2(1) (No. 29), a = 8.1148(1) Angstrom, b = 19.1264(2) Angstrom, c = 2...
C19H16ClN2OS, orthorhombic, Pca2(1) (No. 29), a = 8.1148(1) Angstrom, b = 19.1264(2) Angstrom, c = 2...
In the crystal structures of the title compounds, C15H11Cl2NOS, (1), and C15H11Cl2NO2S, (2), wherein...
C11H9ClN2OS, monoclinic, P121/c1 (no. 14), a = 14.102(2) Å, b = 14.595(1) Å, c = 5.5101(5) Å, β = 92...
In the title compound, C18H13ClN2OS, the thiazolidinone ring is slightly distorted and adopts a enve...
C17H12ClNO4S, monoclinic, P12(1)/c1 (no. 14), a = 13.1203(8) angstrom, b = 16.6201(9) angstrom, c = ...
C17H12ClNO4S, monoclinic, P12(1)/c1 (no. 14), a = 13.1203(8) angstrom, b = 16.6201(9) angstrom, c = ...
C23H16ClN5S, monoclinic, P21/n (no. 14), a = 19.8348(9) Å, b = 8.8376(3) Å, c = 23.8486(10) Å, β = 9...
C20H14N3O2Cl, monoclinic, P21/c (no. 14), a = 15.954(8) Å, b = 8.246(4) Å, c = 14.383(7) Å, β = 116....
The title compounds 2-trichloromethyl-3-phenyl-1,3-thiazolidin-4-one (C10H8Cl3NOS), 1 and 3-(4-chlor...
R factor = 0.030; wR factor = 0.083; data-to-parameter ratio = 22.3. The title compound, C21H19ClN2O...
R factor = 0.048; wR factor = 0.062; data-to-parameter ratio = 15.4. The title compound, C18H16ClN3S...
The asymmetric unit of the title compound, C34H28ClN3O3S, contains two independent molecules (A and ...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C15H14ClNO4, monoclinic, P21/n (no. 14), a = 14.188(3) Å, b = 5.6930(11) Å, c = 17.444(4) Å, β = 95....
C19H16ClN2OS, orthorhombic, Pca2(1) (No. 29), a = 8.1148(1) Angstrom, b = 19.1264(2) Angstrom, c = 2...
C19H16ClN2OS, orthorhombic, Pca2(1) (No. 29), a = 8.1148(1) Angstrom, b = 19.1264(2) Angstrom, c = 2...
In the crystal structures of the title compounds, C15H11Cl2NOS, (1), and C15H11Cl2NO2S, (2), wherein...
C11H9ClN2OS, monoclinic, P121/c1 (no. 14), a = 14.102(2) Å, b = 14.595(1) Å, c = 5.5101(5) Å, β = 92...
In the title compound, C18H13ClN2OS, the thiazolidinone ring is slightly distorted and adopts a enve...
C17H12ClNO4S, monoclinic, P12(1)/c1 (no. 14), a = 13.1203(8) angstrom, b = 16.6201(9) angstrom, c = ...
C17H12ClNO4S, monoclinic, P12(1)/c1 (no. 14), a = 13.1203(8) angstrom, b = 16.6201(9) angstrom, c = ...
C23H16ClN5S, monoclinic, P21/n (no. 14), a = 19.8348(9) Å, b = 8.8376(3) Å, c = 23.8486(10) Å, β = 9...
C20H14N3O2Cl, monoclinic, P21/c (no. 14), a = 15.954(8) Å, b = 8.246(4) Å, c = 14.383(7) Å, β = 116....
The title compounds 2-trichloromethyl-3-phenyl-1,3-thiazolidin-4-one (C10H8Cl3NOS), 1 and 3-(4-chlor...
R factor = 0.030; wR factor = 0.083; data-to-parameter ratio = 22.3. The title compound, C21H19ClN2O...
R factor = 0.048; wR factor = 0.062; data-to-parameter ratio = 15.4. The title compound, C18H16ClN3S...
The asymmetric unit of the title compound, C34H28ClN3O3S, contains two independent molecules (A and ...
C17H13ClN2O2, monoclinic, P21/c (no. 14), a = 5.3601(4) Å, b = 10.6233(7) Å, c = 25.2125(16) Å, β = ...
C15H14ClNO4, monoclinic, P21/n (no. 14), a = 14.188(3) Å, b = 5.6930(11) Å, c = 17.444(4) Å, β = 95....